Home › Funds › Stone Wealth Partners › MRNA
Stone Wealth Partners position in MRNA
MODERNA INC · Health Care
Stone Wealth Partners reported holding 16,884 shares of MRNA (MODERNA INC) in its Q3 2026 13F filing — a position valued at US$3.3M, representing 1.17% of its reported portfolio and ranking #24 among its reported holdings. Stone Wealth Partners has disclosed MRNA holdings in 2 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-05 · Source: SEC EDGAR Form 13F-HR
How Stone Wealth Partners's MRNA position evolved
Stone Wealth Partners first disclosed a stake in MRNA in Q1 2026 at 13,557 shares (US$689K). The position peaked in Q3 2026 at 16,884 shares, worth US$3.3M. Across 2 filings, Stone Wealth Partners held the position steady without any share-count change. The most recent filing (Q3 2026) shows 16,884 shares valued at US$3.3M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 13.56K | $688.70K | New |
| Q3 2026 | 16.88K | $3.34M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MRNA and 13F data
MRNA (MODERNA INC) is a Health Care company. 37 other funds we track also report a position in MRNA — the largest reported positions include Baillie Gifford & Co (US$1.28B), Theleme Partners LLP (US$564.3M), BANQUE PICTET & CIE SA (US$414.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MRNA
- Baillie Gifford & Co 18.21M sh · $1.28B · Q2 2026
- Theleme Partners LLP 8.06M sh · $564.27M · Q2 2026
- BANQUE PICTET & CIE SA 2.15M sh · $414.27M · Q3 2026
- Flagship Pioneering, LLC 4.63M sh · $324.39M · Q2 2026
- Douglas Lane & Associates, LLC 1.16M sh · $223.56M · Q3 2026
- Beau Ventures, LLc 1.00M sh · $192.58M · Q3 2026
- Merck & Co., Inc. 2.31M sh · $161.64M · Q2 2026
- Baron Funds 1.99M sh · $139.32M · Q2 2026
- BAMCO INC /NY/ 1.99M sh · $139.32M · Q2 2026
- IMC-Chicago, LLC 1.70M sh · $119.21M · Q2 2026
More on Stone Wealth Partners
FAQ
How long has Stone Wealth Partners held MRNA?
Stone Wealth Partners has disclosed MRNA holdings in 2 of the last 3 reported quarters, going back to Q1 2026.
What is Stone Wealth Partners's current position in MRNA?
As of Q3 2026, Stone Wealth Partners holds 16.88K shares of MRNA (MODERNA INC), valued at $3.34M, representing 1.17% of its reported portfolio and ranking #24.
Has Stone Wealth Partners been buying or selling MRNA?
In the latest 13F filing (Q3 2026), Stone Wealth Partners newly opened its position in MRNA. The position peaked in Q3 2026 at 16.88K shares.
Which other funds hold MRNA?
Other major institutional holders of MRNA include Baillie Gifford & Co, Theleme Partners LLP, BANQUE PICTET & CIE SA, among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.